The use of remdesivir among pregnant women and associated clinical outcomes in mother and the child

INTRODUCTION: and importance: Management of COVID19 has imposed a global challenge for hospitals, clinicians and patients. The use of medicines to treat clinical symptoms are likely to have adverse effects. COVID19 during pregnancy can be additional challenge since the CT scan cannot be performed in...

Descripción completa

Detalles Bibliográficos
Autores principales: Marzban-Rad, Saeid, Ghafarzadeh, Masoumeh, Bahmani, Sahar, Kazemi, Amenehsadat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047404/
https://www.ncbi.nlm.nih.gov/pubmed/35506126
http://dx.doi.org/10.1016/j.amsu.2022.103681
Descripción
Sumario:INTRODUCTION: and importance: Management of COVID19 has imposed a global challenge for hospitals, clinicians and patients. The use of medicines to treat clinical symptoms are likely to have adverse effects. COVID19 during pregnancy can be additional challenge since the CT scan cannot be performed in pregnant women. CASE PRESENTATION: We reported the case series of use of remdesivir among 23 pregnant women. 5 of these women underwent cesarean section. CLINICAL DISCUSSION: Anticoagulants and dexamethasone were also used to treat these patients. CONCLUSIONS: However, consultancy with the experienced and specialized doctor and timely management and monitoring of the mother and baby is required for effective outcomes.

Ejemplares similares